Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
Retatrutide (LY3437943) Triple GLP-1/GIP/Glucagon Receptor Agonist | Phase 3 Investigational Research Compound Research-Grade Compound Retatrutide (development code LY3437943) is an investigational synthetic 39-amino-acid peptide that agonizes three receptors at once: GLP-1R (the glucagon-like peptide-1 receptor), GIPR (the glucose-dependent insulinotropic polypeptide receptor), and GCGR (the glucagon receptor)
"You've got to put some work into it." Erykah Tuakimoana knows that firsthand -- as she's paid more attention to her eating habits and strength training while on a GLP-1 medication
Flawless Gel Texture: Firm, elastic konjac-style chew provides a satisfying mouthfeel without any mess
d Thrombotic microangiopathy (TMA) Undiagnosed thrombotic thrombocytopenia purpura (TTP), a form of TMA, has a mortality of up to 90%
Side effects that worsen after week four or new symptoms appearing after week eight suggest your body may need a different approachsuch as a dose reduction, extended time at your current dose, or consideration of alternative medications like PlexusDx oral semaglutide or tirzepatide options
Engine Parts > Tilt & Trim Motors" loading="lazy"/>
